Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Schlumberger
SLB
|
+$527M |
| 2 |
Qualcomm
QCOM
|
+$448M |
| 3 |
Marriott International Class A Common Stock
MAR
|
+$369M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$305M |
| 5 |
CELG
Celgene Corp
CELG
|
+$230M |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
+$1.05B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$543M |
| 3 |
Goldman Sachs
GS
|
+$496M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$452M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| 1 | Healthcare | 18.05% |
| 2 | Consumer Discretionary | 14.25% |
| 3 | Technology | 11.26% |
| 4 | Communication Services | 11.22% |
| 5 | Energy | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Prothena Corp
PRTA
$449M
| $19.7M | 0.02% |
874,794
+104,060
| +14% | +$2.35M |
|
|
CSII
427
DELISTED
Cardiovascular Systems, Inc.
CSII
| $19.7M | 0.02% |
631,329
+167,878
| +36% | +$5.23M |
|
428
BOK Financial
BOKF
$7.03B
| $19.7M | 0.02% |
295,350
-24,523
| -8% | -$1.63M |
|
|
PTLA
429
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $18.7M | 0.02% |
641,046
-76,170
| -11% | -$2.22M |
|
430
McEwen Inc.
MUX
$734M
| $18.3M | 0.02% |
634,551
+22,468
| +4% | +$647K |
|
431
Commault Systems
CVLT
$8.23B
| $18.2M | 0.02% |
371,019
-106,607
| -22% | -$5.24M |
|
432
Avient
AVNT
$3.39B
| $18.2M | 0.02% |
+432,639
| New | +$18.2M |
|
|
HELI
433
DELISTED
CHC GROUP LTD SHS NEW (CYM)
HELI
| $17.9M | 0.02% |
70,562
-20,093
| -22% | -$5.09M |
|
|
ORBC
434
DELISTED
ORBCOMM, Inc.
ORBC
| $17.5M | 0.02% |
2,656,511
-2,194
| -0.1% | -$14.5K |
|
|
HMHC
435
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $16.9M | 0.02% |
882,805
+18,063
| +2% | +$346K |
|
|
PKY
436
DELISTED
Parkway, Inc.
PKY
| $16.7M | 0.02% |
808,248
+352,170
| +77% | +$7.27M |
|
|
RAX
437
DELISTED
Rackspace Hosting Inc
RAX
| $16.6M | 0.02% |
493,319
-3,355,492
| -87% | -$113M |
|
|
WBMD
438
DELISTED
WebMD Health Corp.
WBMD
| $16.5M | 0.02% |
342,365
+10,927
| +3% | +$528K |
|
|
AGTC
439
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $16.4M | 0.02% |
+709,007
| New | +$16.4M |
|
|
TBI
440
Trueblue
TBI
$165M
| $16.3M | 0.02% |
591,258
+255,942
| +76% | +$7.06M |
|
441
DNOW Inc
DNOW
$1.6B
| $15.8M | 0.01% |
+436,094
| New | +$15.8M |
|
|
FEIC
442
DELISTED
FEI COMPANY
FEIC
| $15.8M | 0.01% |
173,717
+5,808
| +3% | +$527K |
|
443
IMAX
IMAX
$1.65B
| $15.4M | 0.01% |
541,709
-856,380
| -61% | -$24.4M |
|
|
DATA
444
DELISTED
Tableau Software, Inc.
DATA
| $15.4M | 0.01% |
215,951
-1,406,890
| -87% | -$100M |
|
|
PSXP
445
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $15.2M | 0.01% |
200,975
+9,134
| +5% | +$690K |
|
446
Madrigal Pharmaceuticals
MDGL
$10B
| $15M | 0.01% |
104,855
-8,869
| -8% | -$1.27M |
|
|
VITC
447
DELISTED
VITACOST COM INC COM STK (DE)
VITC
| $14.9M | 0.01% |
2,374,492
+3,641
| +0.2% | +$22.8K |
|
|
ZU
448
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $14.6M | 0.01% |
357,140
-99,509
| -22% | -$4.07M |
|
449
Puma Biotechnology
PBYI
$237M
| $14.2M | 0.01% |
214,547
-215,061
| -50% | -$14.2M |
|
|
ACOR
450
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $14.1M | 0.01% |
+3,496
| New | +$14.1M |
|